Gel Clindovit for external use 1%, 30 g

Klindovit gel d / nar.

approx.

1% tube 30g

Name ENG

CLINDOVIT

Clinical and pharmacological group

Antibiotic of the lincosamide group

ATX code

Clindamycin

Dosage

1% x 30g

Structure

1 g of gel for external use contains: clindamycin (in the form of phosphate) 10 mg Excipients: methyl parahydroxybenzoate (nipagin), allantoin, tocopherol phosphate lauryliminodipropionate disodium, propylene glycol, macrogol 400 (interpolyethylene oxide 400), carbomer, sodium (copolymer) hydroxide, purified water.

Indications

Acne treatment.

Storage conditions and periods

At a temperature of 15-25 degrees.

Expiration date: 2 years

INN / Active ingredient

Clindamycin

Contraindications

Crohn's disease

ulcerative colitis (including history)

pseudomembranous colitis (including a history)

hypersensitivity to clindamycin or lincomycin.

The drug should be used with caution in patients under the age of 12 years (there are no data on safety and efficacy), during lactation (breastfeeding), as well as in patients prone to the development of allergic reactions, and while taking muscle relaxants.

Specifications

Category

Acne

Scope of the drug

Leather

,

Dermatology

Release form

Gel

Manufacturer country

Russia

Package quantity, pcs

one

Scope of application

Dermatology

Minimum age from

12 years

Way of introduction

Outwardly

Vacation conditions

Without recipe

Brand name

Akrikhin

The amount of the dosage form in the primary package

30 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antibiotic lincosamide

Anatomical and therapeutic characteristics

D10AF01 Clindamycin

Dosage form

Gel for external use

Dosage (volume) of the substance in the preparation

Clindamycin (in the form of phosphate) 10 mg

Expiration date in days

730

Package weight, g

thirty

Mode of application

:

The drug is used externally.

< br> The gel is applied in a thin layer on the affected part of the previously cleaned and dried skin 2-3 times / day.

< br> To obtain a therapeutic effect, treatment should be continued for 6-8 weeks, and if necessary, it can be continued up to 6 months.